A large number of previous researches have used MSC as delivery systems to tumor microenvironment, and the therapeutic molecule expressed by MSCs included oncolytic viruses, interleukin 12 (IL-12), IFN-β and TRAIL. The gene discussed is IFNB1; the disease is neoplasm.